The Gross Law Firm Reminds Centene Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 – CNC

Core Viewpoint - Centene Corporation is facing a class action lawsuit due to allegations of providing misleading statements regarding its enrollment and morbidity rates, which led to a significant decline in its stock price after the company withdrew its 2025 guidance [3][4]. Summary by Relevant Sections Allegations - The complaint alleges that Centene's management made overwhelmingly positive statements to investors while concealing material adverse facts about the company's true enrollment and morbidity rates [3]. - On July 1, 2025, Centene issued a press release withdrawing its 2025 guidance, which raised investor concerns about the accuracy of previous public statements [3]. - The company's preliminary analysis indicated that its overall market growth across 22 states, representing 72% of its marketplace membership, was lower than expected, leading to a reduction in guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75 [3]. Stock Price Impact - Following the announcement on July 1, 2025, Centene's stock price plummeted from a closing price of $56.65 per share to $33.78 per share on July 2, 2025, marking a decline of 40.4% [3]. Class Action Details - The class period for the lawsuit is defined as December 12, 2024, to June 30, 2025, and shareholders are encouraged to register for participation [3][4]. - The deadline for shareholders to seek lead plaintiff status is September 8, 2025, and there is no cost or obligation to participate in the case [4]. Firm's Commitment - The Gross Law Firm, which is handling the case, emphasizes its mission to protect investors' rights and ensure companies adhere to responsible business practices [5].